Bacterial Endocarditis and Cerebrovascular Disease

Current Neurology and Neuroscience Reports

Volumn 16, Issue 12, 2016, Pages

  Silver, Brian ^a   Behrouz, Réza ^b   Silliman, Scott ^c  

^a BROWN UNIVERSITY   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Endocarditis; Review; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTICOAGULANT THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONVENTIONAL ANGIOGRAPHY; CRANIOTOMY; EMBOLECTOMY; FIBRINOLYTIC THERAPY; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; MORTALITY RATE; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; SEX DIFFERENCE; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; COMPLICATION; DIAGNOSTIC IMAGING; ENDOCARDITIS, BACTERIAL; INTRACRANIAL ANEURYSM;

ANTI-BACTERIAL AGENTS; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; ENDOCARDITIS, BACTERIAL; HUMANS; INTRACRANIAL ANEURYSM;

EID: 84997170330     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-016-0705-y     Document Type: Review

References (26)

1. • Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368(15):1425–33. Very good review of epidemiology and treatment of endocarditis.
2. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31(15):1890–7.
3. Selton-Suty C et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9.
4. Bannay A et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32(16):2003–15.
5. Morris NA et al. Neurologic complications in infective endocarditis: identification, management, and impact on cardiac surgery. Neurohospitalist. 2014;4(4):213–22.
6. Thiene G, Basso C. Pathology and pathogenesis of infective endocarditis in native heart valves. Cardiovasc Pathol. 2006;15(5):256–63.
7. Dickerman SA et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J. 2007;154(6):1086–94.
8. •• Duval X et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010;152(8):497–504. Detailed evaluation of the findings on brain MRI in patients with infective edocarditis, showing that 82% had asymptomatic or symptomatic DWI lesions.
9. Garcia-Cabrera E et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127(23):2272–84.
10. Walker KA et al. Clinical characteristics and thrombolytic outcomes of infective endocarditis-associated stroke. Neurohospitalist. 2012;2(3):87–91.
11. Kan P et al. First reported use of retrievable stent technology for removal of a large septic embolus in the middle cerebral artery. World Neurosurg. 2012;77(3-4):591. e1-5.
12. Kang G et al. Effectiveness of mechanical embolectomy for septic embolus in the cerebral artery complicated with infective endocarditis. J Korean Med Sci. 2013;28(8):1244–7.
13. Toeg HD et al. Endovascular treatment for cerebral septic embolic stroke. J Stroke Cerebrovasc Dis. 2014;23(5):e375–7.
14. Tornos P et al. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med. 1999;159(5):473–5.
15. Habib G et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.
16. •• Chan KL et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42(5):775–80. Chan and colleagues randomized 115 patients with infective endocarditis to aspirin 325 mg daily or placebo over 4 weeks. They found no significant reduction in the risk of emblic events during that period.
17. Anavekar NS et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis. 2007;44(9):1180–6.
18. Rossi M et al. What is the optimal timing for surgery in infective endocarditis with cerebrovascular complications? Interact Cardiovasc Thorac Surg. 2012;14(1):72–80.
19. Sonneville R et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med. 2011;39(6):1474–81.
20. Klein I et al. Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke. 2009;40(11):3461–5.
21. Okazaki S et al. Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis. Cerebrovasc Dis. 2011;32(5):483–8.
22. Ducruet AF et al. Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev. 2010;33(1):37–46.
23. Chapot R et al. Endovascular treatment of cerebral mycotic aneurysms. Radiology. 2002;222(2):389–96.
24. Kannoth S et al. Proposed diagnostic criteria for intracranial infectious aneurysms. J Neurol Neurosurg Psychiatry. 2008;79(8):943–6.
25. White PM et al. Intracranial aneurysms: CT angiography and MR angiography for detection prospective blinded comparison in a large patient cohort. Radiology. 2001;219(3):739–49.
26. Gross BA, Puri AS. Endovascular treatment of infectious intracranial aneurysms. Neurosurg Rev. 2013;36(1):11–9. discussion 19.